2020-12-14
The FDA has accepted Toralgen’s polybile nanopill into its Emerging Technology Program. Getting into the program sets Toralgen up to meet with the FDA’s emerging technology team to resolve potential technical and regulatory issues that could slow the progress of its nanopill.
